Search results
BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 10 hours agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost all of its expected 2024 revenues would ...
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
RTT News· 10 hours agoGerman Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a loss in its first quarter, compared to prior year's profit with sharply ...
BioNTech Swings to Net Loss on Lower Covid Vaccine Sales
Market Watch· 10 hours agoBioNTech swung to a net loss in the first quarter, when revenue plummeted after a sharp decline in its Covid-19 vaccine sales. The German biotechnology company, listed on ...
BioNTech's Outlook Gives Vaccine Maker a Shot in the Arm
Investopedia· 14 hours agoAmerican depositary receipts (ADRs) of BioNTech (BNTX) were down less than 1% in intraday trading...
BioNTech Slips To Loss In Q1
RTT News· 10 hours agoImmunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a net loss of 315.1 million euros or 1.31 euros per share for the first quarter, compared to net profit of 502.
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 6 days agoOn BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the...
Kestra Private Wealth Services LLC Buys New Position in BioNTech SE (NASDAQ:BNTX)
ETF DAILY NEWS· 2 days agoKestra Private Wealth Services LLC bought a new stake in shares of BioNTech SE (NASDAQ:BNTX – Free Report) in the 4th quarter, according to the company in its most recent ...
Van ECK Associates Corp Sells 17,318 Shares of BioNTech SE (NASDAQ:BNTX)
ETF DAILY NEWS· 4 days agoVan ECK Associates Corp cut its position in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 13.7% in the fourth quarter, according to the company in its most recent disclosure ...
Why Earnings Season Could Be Great for BioNTech (BNTX)
Zacks via Yahoo Finance· 3 days agoInvestors are always looking for stocks that are poised to beat at earnings season and BioNTech SE...
Why Earnings Season Could Be Great for BioNTech (BNTX)
Zacks· 4 days agoFree Report) may be one such company. In fact, the Most Accurate Estimate for the current quarter is currently pegged at an earnings of 14 cents per share for BNTX, compared to a broader Zacks ...